Localisation of treatment-resistant areas in patients on biologics.

CONCLUSION: In real-world clinical practice, the most common sites of recalcitrant psoriasis in patients treated with biologic agents are the anterior lower leg, the posterior lower leg, and the elbows. Recalcitrant psoriasis in no specific area caused a greater impact on quality of life than any other area. This article is protected by copyright. All rights reserved.
PMID: 30677133 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - January 24, 2019 Category: Dermatology Authors: Hjuler KF, Iversen L, Rasmussen MK, Kofoed K, Skov L, Zachariae C Tags: Br J Dermatol Source Type: research